These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11773299)

  • 21. Reflections on the development of resistance during therapy for advanced breast cancer. Implications of high levels of activity of docetaxel in anthracycline-resistant breast cancer patients.
    Ravdin PM
    Eur J Cancer; 1997 Aug; 33 Suppl 7():S7-10. PubMed ID: 9486096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer.
    Bellon JR; Lindsley KL; Ellis GK; Gralow JR; Livingston RB; Austin Seymour MM
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):393-7. PubMed ID: 10974452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?
    Nabholtz JM; Tonkin K; Smylie M; Au HJ; Lindsay MA; Mackey J
    Expert Opin Pharmacother; 2000 Jan; 1(2):187-206. PubMed ID: 11249542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of taxanes in the treatment of breast cancer.
    Capri G; Tarenzi E; Fulfaro F; Gianni L
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):68-75. PubMed ID: 8614849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adjuvant chemotherapy with taxoid-containing drugs in breast cancer: soon to be expected in the Netherlands].
    Nortier JW
    Ned Tijdschr Geneeskd; 2004 Jul; 148(31):1524-8. PubMed ID: 15366720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.
    Bedard PL; Di Leo A; Piccart-Gebhart MJ
    Nat Rev Clin Oncol; 2010 Jan; 7(1):22-36. PubMed ID: 19997076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use and abuse of taxanes in the management of metastatic breast cancer.
    Bernard-Marty C; Cardoso F; Piccart MJ
    Eur J Cancer; 2003 Sep; 39(14):1978-89. PubMed ID: 12957452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer.
    Estévez LG; Gradishar WJ
    Clin Cancer Res; 2004 May; 10(10):3249-61. PubMed ID: 15161677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefit of taxanes as adjuvant chemotherapy for early breast cancer: pooled analysis of 15,500 patients.
    Bria E; Nistico C; Cuppone F; Carlini P; Ciccarese M; Milella M; Natoli G; Terzoli E; Cognetti F; Giannarelli D
    Cancer; 2006 Jun; 106(11):2337-44. PubMed ID: 16649217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer.
    Lister-Sharp D; McDonagh MS; Khan KS; Kleijnen J
    Health Technol Assess; 2000; 4(17):1-113. PubMed ID: 11074389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical overview of the taxanes.
    Goldspiel BR
    Pharmacotherapy; 1997; 17(5 Pt 2):110S-125S. PubMed ID: 9322878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the efficacy and safety of docetaxel as monotherapy in metastatic breast cancer.
    Crown J
    Semin Oncol; 1999 Feb; 26(1 Suppl 3):5-9. PubMed ID: 10203264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary chemotherapy with docetaxel for the management of breast cancer.
    Valero V
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):35-43. PubMed ID: 12108896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.
    Fisher B; Jeong JH; Dignam J; Anderson S; Mamounas E; Wickerham DL; Wolmark N
    J Natl Cancer Inst Monogr; 2001; (30):62-6. PubMed ID: 11773294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg.
    Dang C; Hudis C
    Clin Breast Cancer; 2006 Apr; 7(1):51-8. PubMed ID: 16764744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docetaxel: an update of its use in advanced breast cancer.
    Figgitt DP; Wiseman LR
    Drugs; 2000 Mar; 59(3):621-51. PubMed ID: 10776837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant therapy of primary breast cancer: a review of key findings from the 7th international conference, St. Gallen, February 2001.
    Aapro MS
    Oncologist; 2001; 6(4):376-85. PubMed ID: 11524557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current status of docetaxel in solid tumors. An M. D. Anderson Cancer Center Review.
    Hong WK
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):9-15. PubMed ID: 12108903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The taxanes: an update.
    Crown J; O'Leary M
    Lancet; 2000 Apr; 355(9210):1176-8. PubMed ID: 10791395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.